Greykasell Wealth Strategies’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.72K Sell
44
-268
-86% -$74.1K ﹤0.01% 381
2026
Q1
$92K Buy
312
+44
+16% +$13.1K 0.04% 198
2025
Q4
$73K Buy
+268
New +$72.8K 0.03% 209

Other funds holding CME

Greykasell Wealth Strategies's CME Position: Q2 2026 in Review

Greykasell Wealth Strategies reduced its CME Group (CME) stake by 86% in Q2 2026, selling an estimated $74.1K and leaving 44 shares worth $9.72K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

Greykasell Wealth Strategies first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $92K in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Greykasell Wealth Strategies held 44 shares of CME Group worth $9.72K as of Q2 2026.
  • Greykasell Wealth Strategies sold 268 CME Group shares in Q2 2026, an estimated $74.1K.
  • CME Group made up ﹤0.01% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #381 holding.
  • Greykasell Wealth Strategies first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
  • Greykasell Wealth Strategies's CME Group position peaked at $92K in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.